Tan, X., Wang, Y., Wu, Z., Wei, W., Zhou, Q., Zhang, C., Deng, X., Zheng, R., Zeng, J., Chen, Q., Yao, K. (2025). Formula-01: A phase Ⅱ study of disitamab vedotin (RC48) intravenous injection combined with BCG intravesical instillation in high-risk non-muscle invasive bladder cancer with HER2 high expression.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.tps894